These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 489978)

  • 1. The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.
    Roder JC
    J Immunol; 1979 Nov; 123(5):2168-73. PubMed ID: 489978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect.
    Roder JC; Lohmann-Matthes ML; Domzig W; Wigzell H
    J Immunol; 1979 Nov; 123(5):2174-81. PubMed ID: 158612
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T; Alm G; Stålhandshe T
    J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and regulation of progenitor marrow elements by NK cells in the mouse.
    O'Brien T; Kendra J; Stephens H; Knight R; Barrett AJ
    Immunology; 1983 Aug; 49(4):717-25. PubMed ID: 6192081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
    Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O
    Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
    Hackett J; Bennett M; Kumar V
    J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression of natural antitumor resistance of C57BL/6 mice by leukemogenic doses of radiation and restoration of resistance by transfer of bone marrow or spleen cells from normal, but not beige, syngeneic mice.
    Gorelik E; Herberman RB
    J Natl Cancer Inst; 1982 Jul; 69(1):89-93. PubMed ID: 7047834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
    Flexman JP; Shellam GR
    Clin Exp Immunol; 1984 Jan; 55(1):229-38. PubMed ID: 6198116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS; Bennett M; Kumar V
    Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
    Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
    J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
    Kärre K; Klein GO; Kiessling R; Klein G
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of role of natural killer cells in radiation-induced leukemogenesis in mice.
    Gorelik E; Rosen B; Copeland D; Weatherly B; Herberman RB
    J Natl Cancer Inst; 1984 Jun; 72(6):1397-403. PubMed ID: 6374239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I; Miller SC
    Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.